Aashka Hospitals

Why is Aashka Hospitals Ltd falling/rising?

As of 22-Jun, Aashka Hospitals Ltd's stock price is stable at 81.25, with an 8.33% increase over the past week and significant investor interest indicated by a 191.67% rise in delivery volume. Despite some intraday volatility, the overall trend remains positive.

As of 22-Jun, Aashka Hospitals Ltd's stock price is currently stable at 81.25, showing no change (0.00%). However, the stock has demonstrated a positive trend recently, with an 8.33% increase over the past week, which outperformed the Sensex's gain of 1.09% during the same period. Additionally, the stock has gained 8.67% over the last two days, indicating a consecutive gain.<BR><BR>Despite opening with a loss of 4.11% today and touching an intraday low of Rs 77, the overall performance suggests a rising interest among investors, as evidenced by a significant increase in delivery volume, which rose by 191.67% compared to the 5-day average. This indicates that more investors are willing to hold the stock, contributing to its upward momentum in the short term.<BR><BR>In summary, while the stock has faced some volatility today, the recent gains and increased investor participation suggest a rising trend for Aashka Hospitals Ltd.

Which are the latest news on Aashka Hospitals?

What does Aashka Hospitals do?

Aashka Hospitals Ltd is a micro-cap company in the hospital industry, incorporated in 2012, with no recent revenue or profit data available. Its market cap is INR 176 Cr, with a P/E ratio of 62.00 and a debt-equity ratio of 0.04.

Overview: <BR>Aashka Hospitals Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Aashka Hospitals Limited was originally incorporated as a Private Limited Company under the name "Aashka Hospitals Private Limited" on November 09, 2012. There are no reported status changes, and revenue and profit data are not available for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 176 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 62.00 <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.04 <BR>Return on Equity: 2.74% <BR>Price-to-Book: 1.70 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

How big is Aashka Hospitals?

As of 10th June, Aashka Hospitals Ltd has a market capitalization of 176.00 Cr, classifying it as a Micro Cap company, with no valid financial data available for net sales or net profit for the latest four quarters. The latest balance sheet shows Shareholder's Funds of 99.54 Cr and Total Assets of 116.05 Cr as of March 2025.

As of 10th June, <BR><BR>Market Cap: Aashka Hospitals Ltd has a market capitalization of 176.00 Cr, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for net sales or net profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 99.54 Cr and Total Assets valued at 116.05 Cr.

Who are in the management team of Aashka Hospitals?

The management team of Aashka Hospitals includes Bipinchandra Shah (Chairman & Managing Director), Dr. Parag Thaker, Shreyarthi Shah (Directors), Hiteshkumar Shah (Independent Director), Umang Shah (Additional Director), and Mayank Agarwal (Company Secretary & Compliance Officer).

The management team of Aashka Hospitals includes the following individuals:<BR><BR>1. Bipinchandra Shah - Chairman & Managing Director<BR>2. Dr. Parag Thaker - Director<BR>3. Shreyarthi Shah - Director<BR>4. Hiteshkumar Shah - Independent Director<BR>5. Umang Shah - Additional Director<BR>6. Mayank Agarwal - Company Secretary & Compliance Officer<BR><BR>If you have any more questions about Aashka Hospitals or its operations, feel free to ask!

Who are the peers of the Aashka Hospitals?

Aashka Hospitals' peers include Asarfi Hospital, Lotus Eye Hospital, and Fortis Malar, among others. In terms of management risk, Aashka Hospitals is rated below average, with a 1-year return of -24.05%, better than Fortis Malar's -29.66% but lower than Lotus Eye Hospital's 66.04%.

Peers: The peers of Aashka Hospitals are Asarfi Hospital, Lotus Eye Hospit, Abate As Indust, Fortis Malar, Vaidya Sane, KHFM Hospitality, Nephro Care, Aprameya Enginee, and Maitreya Medica.<BR><BR>Quality Snapshot: Excellent management risk is observed at Nephro Care and Aprameya Enginee, while Average management risk is found at Asarfi Hospital and Vaidya Sane. Below Average management risk is noted at Lotus Eye Hospit, Aashka Hospitals, Abate As Indust, Fortis Malar, KHFM Hospitality, Maitreya Medica, and the rest. Growth is Excellent at Nephro Care, Good at Asarfi Hospital and Vaidya Sane, Average at Aprameya Enginee, and Below Average at Lotus Eye Hospit, Aashka Hospitals, Abate As Indust, Fortis Malar, KHFM Hospitality, Maitreya Medica, and the rest. Capital Structure is Good at Asarfi Hospital, Vaidya Sane, and Aprameya Enginee, Average at Aashka Hospitals, Abate As Indust, and the rest, and Below Average at Lotus Eye Hospit, Fortis Malar, KHFM Hospitality, Nephro Care, and Maitreya Medica.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Lotus Eye Hospit at 66.04%, while the peer with the lowest is Fortis Malar at -29.66%. Aashka Hospitals has a 1-year return of -24.05%, which is higher than Fortis Malar but lower than Lotus Eye Hospit. Additionally, Fortis Malar, KHFM Hospitality, and Maitreya Medica have negative six-month returns.

How has been the historical performance of Aashka Hospitals?

Aashka Hospitals has experienced fluctuating financial performance, with net sales declining from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, while profitability improved, moving from a loss in March 2023 to profits by March 2025. Despite a decrease in total assets, cash flow from operations significantly improved, reaching INR 9 crore in March 2025.

Answer:<BR>The historical performance of Aashka Hospitals shows fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aashka Hospitals' net sales have seen a decline from INR 39.73 crore in March 2022 to INR 22.65 crore in March 2025, with a slight decrease from INR 22.87 crore in March 2024. The total operating income followed a similar trend, peaking at INR 39.73 crore in March 2022 and dropping to INR 22.65 crore by March 2025. The total expenditure, excluding depreciation, decreased from INR 31.47 crore in March 2022 to INR 18.37 crore in March 2025. Operating profit (PBDIT) also fluctuated, reaching a high of INR 9.92 crore in March 2021 but falling to INR 4.28 crore in March 2025. Profit before tax improved from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.87 crore in March 2025. Profit after tax followed suit, moving from a loss of INR 2.57 crore in March 2023 to a profit of INR 3.27 crore in March 2025. The company's total assets decreased from INR 129.12 crore in March 2022 to INR 116.05 crore in March 2025, while total liabilities also declined from INR 129.12 crore to INR 116.05 crore during the same period. Cash flow from operating activities improved significantly, reaching INR 9 crore in March 2025, compared to a negative cash flow of INR 62 crore in March 2022. Overall, Aashka Hospitals has shown a recovery in profitability and cash flow in recent years, despite a decline in sales and total assets.

Who are the top shareholders of the Aashka Hospitals?

The top shareholder of Aashka Hospitals is Bipinchandra Dineshbhai Shah, holding 49.63%, with no pledged promoter holdings. The highest public shareholder is Mohit Prakash Jalan at 2.38%, while individual investors own 30.16% of the shares.

The top shareholders of Aashka Hospitals are primarily the promoters, with Bipinchandra Dineshbhai Shah holding the largest share at 49.63%. There are no pledged promoter holdings, and the company does not have any mutual fund or foreign institutional investor (FII) holdings. The highest public shareholder is Mohit Prakash Jalan, who holds 2.38%. Additionally, individual investors collectively hold 30.16% of the company's shares.

Is Aashka Hospitals overvalued or undervalued?

As of May 27, 2025, Aashka Hospitals is considered overvalued with a PE ratio of 91.61 and an EV to EBITDA of 57.47, significantly higher than its peers, despite a low ROE of 2.58% and recent underperformance compared to the market.

As of 27 May 2025, Aashka Hospitals has moved from a grade of "does not qualify" to "very expensive." The company is currently overvalued, with a PE ratio of 91.61, an EV to EBITDA of 57.47, and a ROE of 2.58%. In comparison, peers such as Apollo Hospitals Enterprise Ltd. have a significantly lower PE ratio of 69.03 and an EV to EBITDA of 34.71, while Fortis Healthcare Ltd. stands at a PE of 68.71 and an EV to EBITDA of 37.55, indicating that Aashka is trading at a premium relative to its competitors.<BR><BR>The high valuation metrics suggest that Aashka Hospitals is not justified by its financial performance, especially considering its low ROCE of 1.16%. Additionally, while the stock has shown strong performance over the past year with a return of 21.56% compared to the Sensex's 7.55%, the year-to-date performance of -11.11% against the Sensex's 5.56% indicates a potential correction ahead. Overall, the current valuation does not align with the company's financial fundamentals, reinforcing the conclusion that Aashka Hospitals is overvalued.

What is the technical trend for Aashka Hospitals?

As of April 30, 2025, Aashka Hospitals exhibits a mildly bearish trend, driven by bearish MACD and moving averages, despite some mixed signals from Bollinger Bands and KST.

As of 30 April 2025, the technical trend for Aashka Hospitals has changed from sideways to mildly bearish. The weekly MACD is bearish, while the monthly MACD is mildly bearish, indicating a negative momentum shift. The daily moving averages also reflect a bearish stance. Although the weekly Bollinger Bands are bearish, the monthly Bollinger Bands show a mildly bullish outlook, suggesting some potential for recovery. The KST indicates a mildly bullish trend on the weekly and bullish on the monthly, which contrasts with the overall bearish sentiment. The Dow Theory shows no trend on the weekly and mildly bearish on the monthly, further supporting the bearish outlook. Overall, the current stance is mildly bearish, driven primarily by the bearish indicators in MACD and moving averages, despite some mixed signals from KST and Bollinger Bands.

When is the next results date for Aashka Hospitals?

No Upcoming Board Meetings

Has Aashka Hospitals declared dividend?

No Dividend History Available